Article

Carl Zeiss Meditec owns majority interest

Jena, Germany—Carl Zeiss Meditec AG has acquired 87.1% of IOLTech SA, the French ophthalmic surgery specialist Carl Zeiss Meditec has committed to taking over.

Jena, Germany-Carl Zeiss Meditec AG has acquired 87.1% of IOLTech SA, the French ophthalmic surgery specialist Carl Zeiss Meditec has committed to taking over.

The German company had acquired about 63% of the IOLTech shares from its former principal shareholder as of Feb. 1. About two-thirds of the remaining minority shareholders accepted Carl Zeiss Meditec's voluntary public takeover bid by April 5.

"The company considers this result of the takeover bid as a further successful milestone on Carl Zeiss Meditec's way to the complete takeover of IOLTech," Carl Zeiss Meditec announced.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.